Methotrexate impacts conserved pathways in diverse human gut bacteria leading to decreased host immune activation
Year: 2021
Type: article
Source: Cell Host & Microbe
Institutions: University of California, San Francisco, Pennsylvania State University, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, New York University, Chan Zuckerberg Biohub San Francisco
Language: English
Topic: Gut microbiota and health
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
Funders: Damon Runyon Cancer Research Foundation, Rheumatology Research Foundation, Sandler Foundation, Pennsylvania State University, Searle Scholars Program, Ministerio de Economía y Competitividad, MedImmune, National Institutes of Health, University of California, San Francisco, National Heart, Lung, and Blood Institute, National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Center for Research Resources, National Center for Advancing Translational Sciences
Awards: G1239756754, Acquisition of an Orbitrap Fusion Lumos Tribid Mass Spectrometer to Accelerate Metabolite Identification and Pathway Analysis, G1629256956, G1794545851, PEDIATRIC CLINICAL RESEARCH CENTER, G2214540629, G2288028266, G2504833279, G3064501752, G3320014004, G3771695753, G425979834, G5073458855, G5573986191, G572470501, Employing the gut microbiome to accelerate effective initiation of rheumatoid arthritis therapy, Diabetes Research Center, G8961960431, G9000030680, G9000058028, G9000205022, NRSA Training Core, Academic Rheumatology and Clinical Immunology
OpenAlex ID: W3119807729